Designing drugs against Hsp90 for cancer therapy Book Section
| Authors: | Ochiana, S. O.; Taldone, T.; Chiosis, G. |
| Editor: | Houry, W. A. |
| Article/Chapter Title: | Designing drugs against Hsp90 for cancer therapy |
| Abstract: | Heat shock protein 90 (Hsp90) is a molecular chaperone exploited by cancer cells to aid the function of numerous oncoproteins. The recognition of Hsp90 as a critical facilitator for oncogene addiction and survival of the cancer cell has opened a promising new niche for cancer treatment. The serendipitous discovery that the broad spectrum anticancer activity of the natural products geldanamycin (GM) and radicicol (RD) was a result of inhibition of Hsp90 resulted in the development of improved derivatives of these natural products. One of these was 17-allylaminogeldanamycin (17-AAG), a closely related analog of GM, and was in fact the first Hsp90 inhibitor to enter the clinic. However, GM and its analogs suffer from poor "drug-like" properties and this served as a strong impetus for the development of novel synthetic Hsp90 inhibitors. These efforts resulted in the development of numerous potent synthetic small molecule inhibitors with significant scaffold diversity as well as superior pharmacokinetic and toxicity profile to have entered clinical trials. This review highlights the drug discovery efforts pertaining to the development of the first and second-generation Hsp90 inhibitors, and also gleans over their individual promise as clinical agents for anticancer therapy. © Springer Science+Business Media New York 2014. All rights reserved. |
| Book Title: | The Molecular Chaperones Interaction Networks in Protein Folding and Degradation |
| ISBN: | 978-1-4939-1129-5 |
| Publisher: | Springer |
| Publication Place: | New York, NY |
| Date Published: | 2014-01-01 |
| Start Page: | 151 |
| End Page: | 183 |
| Language: | English |
| DOI: | 10.1007/978-1-4939-1130-1_7 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Book Chapter: 7 -- Export Date: 6 March 2020 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work